Charles Schwab’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.51M Buy
958,700
+123,654
+15% +$453K ﹤0.01% 2480
2025
Q1
$3.61M Sell
835,046
-90,614
-10% -$391K ﹤0.01% 2410
2024
Q4
$2.96M Sell
925,660
-22,791
-2% -$72.9K ﹤0.01% 2549
2024
Q3
$2.71M Buy
948,451
+23,675
+3% +$67.7K ﹤0.01% 2612
2024
Q2
$2.59M Buy
924,776
+14,037
+2% +$39.3K ﹤0.01% 2612
2024
Q1
$2.59M Buy
910,739
+76,731
+9% +$218K ﹤0.01% 2520
2023
Q4
$3.41M Buy
834,008
+7,516
+0.9% +$30.7K ﹤0.01% 2464
2023
Q3
$2.63M Buy
826,492
+28,326
+4% +$90.1K ﹤0.01% 2517
2023
Q2
$2.65M Buy
798,166
+9,013
+1% +$29.9K ﹤0.01% 2467
2023
Q1
$1.68M Buy
789,153
+1,092
+0.1% +$2.33K ﹤0.01% 2569
2022
Q4
$2.12M Buy
788,061
+12,998
+2% +$35K ﹤0.01% 2556
2022
Q3
$2.51M Buy
775,063
+107,118
+16% +$347K ﹤0.01% 2520
2022
Q2
$3.26M Sell
667,945
-5,417
-0.8% -$26.4K ﹤0.01% 2377
2022
Q1
$5.13M Buy
673,362
+88,581
+15% +$675K ﹤0.01% 2264
2021
Q4
$5.4M Sell
584,781
-34,051
-6% -$315K ﹤0.01% 2307
2021
Q3
$8.81M Buy
618,832
+241,350
+64% +$3.44M ﹤0.01% 2082
2021
Q2
$6.27M Buy
377,482
+731
+0.2% +$12.2K ﹤0.01% 2234
2021
Q1
$6.87M Buy
376,751
+17,125
+5% +$312K ﹤0.01% 2144
2020
Q4
$2.71M Buy
359,626
+193,950
+117% +$1.46M ﹤0.01% 2510
2020
Q3
$637K Buy
165,676
+16,196
+11% +$62.3K ﹤0.01% 2813
2020
Q2
$575K Buy
149,480
+26,386
+21% +$101K ﹤0.01% 2776
2020
Q1
$398K Buy
123,094
+6,606
+6% +$21.4K ﹤0.01% 2790
2019
Q4
$561K Buy
116,488
+57,572
+98% +$277K ﹤0.01% 2778
2019
Q3
$388K Sell
58,916
-27,579
-32% -$182K ﹤0.01% 2897
2019
Q2
$658K Buy
86,495
+23,180
+37% +$176K ﹤0.01% 2709
2019
Q1
$475K Buy
+63,315
New +$475K ﹤0.01% 2779